Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

- PMLiVE

Alnylam pulls lead drug revusiran after deaths in phase III trial

US biotech has yet to determine the cause of the amyloidosis and cardiomyopathy study fatalities

- PMLiVE

Regional NHS pulmonary rehabilitation video campaign launched

Aims to boost referral rates among GPs in the north east of England

- PMLiVE

UCB launches UK product helpline for patients and HCPs

UCBCares will answer treatment queries and use feedback to drive innovation

- PMLiVE

Teva sells UK and Ireland assets to Intas Pharma for £603m

Generics portfolio and manufacturing facility gain set to double Indian firm’s UK sales

- PMLiVE

Cytovation expands management team

Raj Airey and Federico Grego join the Norwegian biotech

- PMLiVE

Ashfield Meetings & Events appoints board member

Laura Brown becomes senior vice president of operations

Roche Basel Switzerland

Roche snags pair of FDA breakthrough designations

Accelerates approval process for NSCLC treatment Alecensa and immunotherapy Actemra

National Institute for Health and Care Excellence NICE logo

NICE turns down Keytruda for lung cancer in draft guidance

Says long-term benefits for advanced non-small cell lung cancer treatment not proven

- PMLiVE

Lucid adds to senior leadership team

Shula Sarner and Tanya Goodyear join the med comms agency

Dr. Thomas Blatter has been appointed Vice President, DACH Region

Dr. Thomas Blatter has been appointed VP DACH region to lead Anthill’s activities in the region, effective immediately.

Anthill Agency

- PMLiVE

IMS Health and Quintiles complete merger

Launch global healthcare information and technology specialist QuintilesIMS

- PMLiVE

Another failed trial knocks back AZ’s plan to grow Brilinta

Rests hopes on ongoing diabetes study but looks set to fall short of $3.5bn annual target

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links